Previous 10 | Next 10 |
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed healthcare veteran, Dr. Connie Mariano , to its board of directors. Following her appointment, the board will have eight members...
For Q3, Conversion Labs ([[CVLB]] +3.5%) expects revenue of ~$11.2M, up 23% Q/Q and up 254% Y/Y driven by another strong month in September, with revenues totaling ~$3.9M, up 258% Y/Y.It expects to report Annual recurring revenue ((ARR)) from subscriptions to products and servi...
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its third quarter ended September 30, 2020. Revenues for the third quarter are expected to total approx...
Conversion Labs ( OTCQB:CVLB ) announced equity investment by a select group of private investors and family offices, including investors David Blitzer and Wes Edens, for $3.5M. More news on: Conversion Labs, Inc., Healthcare stocks news, Read more ...
NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has completed its previously announced equity investment by a select group of private investors and family offices, including investors David Bl...
NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has reported record revenues of $3.7 million for the month of August, up more than 267% versus August 2019. August results indicate an ov...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
Conversion Labs ( OTCQB:CVLB ) issues $3.5M Series B Convertible Preferred Stock to select group of private investors and family offices. More news on: Conversion Labs, Inc., , Read more ...
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, announced that a select group of private investors and family offices have agreed to purchase $3.5 million of its newly issued Series B Convertible...
NEW YORK, NY / ACCESSWIRE / August 20, 2020 / Conversion Labs, Inc. (OTCQB:CVLB), a direct-to-consumer telemedicine and wellness company, has been invited to present at LD Micro 500 virtual institutional investor conference being held on September 1-4, 2020. CEO of Conversion Labs, Just...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17...
NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the official launch of its subscription-based primary care and concierge ser...
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continu...